Novant Health Cancer Institute

Charlotte, North Carolina 28204

6 studies enrolling now · 10 studies all time

What they study most

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapsed or Refractory, Breast Cancer, Cervical Cancer, Chemoradiotherapy-Induced Severe Oral Mucositis, HER2-positive Solid Cancers, MDS (Myelodysplastic Syndrome), Melanoma, Multiple Myeloma, Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma

Studies at this site

• A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer — Recruiting now
• A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
• A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — Recruiting now
• Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma — Recruiting now
• Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS — Recruiting now
• A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma — Stopped early
• A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies — Starting soon
• NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma — Stopped early
• Study of MT-5111 in HER2-positive Solid Tumors — Stopped early
• Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. — Stopped early